Active, not recruitingPhase 3NCT05910450
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cassiopea SpA
- Principal Investigator
- Alessandro Mazzetti, M.D., MDCassiopea SpA
- Intervention
- Clascoterone 5% solution(drug)
- Enrollment
- 703 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2023 – 2026
Study locations (24)
- The Petrus Center for Aesthetic Surgery and Hair Transplantation, North Little Rock, Arkansas, United States
- Therapeutics Clinical Research, San Diego, California, United States
- Mayo Clinic, Department of Dermatology, Jacksonville, Florida, United States
- University of Miami, Miami, Florida, United States
- DelRicht Research, Baton Rouge, Louisiana, United States
- DelRicht Research, New Orleans, Louisiana, United States
- Henry Ford Health, Detroit, Michigan, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- JDR Dermatology Research, Las Vegas, Nevada, United States
- Hassman Research Institute, Berlin, New Jersey, United States
- Diane S. Berson MD, PLLC, New York, New York, United States
- Derm Research Center of New York, Inc., Stony Brook, New York, United States
- On Site Clinical Solutions, Charlotte, North Carolina, United States
- DermResearch, Austin, Texas, United States
- DelRicht Research, Frisco, Texas, United States
- +9 more locations on ClinicalTrials.gov
Collaborators
Ergomed PLC · Pharmapace Inc · Canfield Scientific Inc. · ICON Clinical Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05910450 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC